GeneDx Holdings Corp. Interest Expense
GeneDx Holdings Corp. (WGS) reported Interest Expense of $626.00 thousand for the 3-month period ending 2023-06-30, per its 10-Q filed 2023-08-08.
Discontinued › Expense Statement › Interest Expense
us-gaap:InterestExpense · last filed 2023-08-08
- GeneDx Holdings Corp. interest expense for the quarter ending 2023-06-30 was $626.00K, a 20.76% decline year-over-year.
- GeneDx Holdings Corp. interest expense for the quarter ending 2023-03-31 was $767.00K, a 5.07% decline year-over-year.
- GeneDx Holdings Corp. interest expense for the quarter ending 2022-12-31 was $803.00K, a 13.58% increase year-over-year.
- GeneDx Holdings Corp. interest expense for the quarter ending 2022-09-30 was $806.00K, a 18.01% increase year-over-year.
- GeneDx Holdings Corp. interest expense for fiscal 2022 was $3.21M, a 13.12% increase from fiscal 2021.
- GeneDx Holdings Corp. interest expense for fiscal 2021 was $2.83M, a 14.59% increase from fiscal 2020.
- GeneDx Holdings Corp. interest expense for fiscal 2020 was $2.47M, a 215.96% increase from fiscal 2019.
- GeneDx Holdings Corp. interest expense for fiscal 2019 was $783.00K.
| Period end | Interest Expense 3 month | Interest Expense 6 month | Interest Expense 9 month | Interest Expense 12 month |
|---|---|---|---|---|
| 2023-06-30 | $626.00K 10-Q · filed 2023-08-08 | $1.39M 10-Q · filed 2023-08-08 | $2.20M derived: sum of 3 quarters · filed 2023-08-08 | $3.00M derived: sum of 4 quarters · filed 2023-08-08 |
| 2023-03-31 | $767.00K 10-Q · filed 2023-05-09 | $1.57M derived: sum of 2 quarters · filed 2023-05-09 | $2.38M derived: sum of 3 quarters · filed 2023-05-09 | $3.17M derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-12-31 | $803.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $1.61M derived: sum of 2 quarters · filed 2023-03-16 | $2.40M derived: sum of 3 quarters · filed 2023-08-08 | $3.21M 10-K · filed 2023-03-16 |
| 2022-09-30 | $806.00K 10-Q · filed 2022-11-14 | $1.60M derived: sum of 2 quarters · filed 2023-08-08 | $2.40M 10-Q · filed 2022-11-14 | $3.11M derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-06-30 | $790.00K 10-Q · filed 2023-08-08 | $1.60M 10-Q · filed 2023-08-08 | $2.31M derived: sum of 3 quarters · filed 2023-08-08 | $2.99M derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-03-31 | $808.00K 10-Q · filed 2023-05-09 | $1.51M derived: sum of 2 quarters · filed 2023-05-09 | $2.20M derived: sum of 3 quarters · filed 2023-05-09 | $2.92M derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | $707.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $1.39M derived: sum of 2 quarters · filed 2023-03-16 | $2.11M derived: sum of 3 quarters · filed 2023-03-16 | $2.83M 10-K · filed 2023-03-16 |
| 2021-09-30 | $683.00K 10-Q · filed 2022-11-14 | $1.41M derived: sum of 2 quarters · filed 2022-11-14 | $2.13M 10-Q · filed 2022-11-14 | $2.78M derived: sum of 4 quarters · filed 2023-03-16 |
| 2021-06-30 | $722.00K 10-Q · filed 2022-08-15 | $1.45M 10-Q · filed 2022-08-15 | $2.09M derived: sum of 3 quarters · filed 2023-03-16 | $2.73M derived: sum of 4 quarters · filed 2023-03-16 |
| 2021-03-31 | $723.00K 10-Q · filed 2022-05-12 | $1.37M derived: sum of 2 quarters · filed 2023-03-16 | $2.01M derived: sum of 3 quarters · filed 2023-03-16 | |
| 2020-12-31 | $648.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $1.28M derived: sum of 2 quarters · filed 2023-03-16 | $2.47M 10-K · filed 2023-03-16 | |
| 2020-09-30 | $637.00K 10-Q · filed 2021-11-15 | $1.83M 10-Q · filed 2021-11-15 | ||
| 2019-12-31 | $783.00K 10-K · filed 2022-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B |